NCT03157154View on ClinicalTrials.gov

Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies

CompletedOBSERVATIONAL
Enrollment

259

Participants

Timeline

Start Date

June 27, 2017

Primary Completion Date

July 30, 2017

Study Completion Date

July 30, 2017

Conditions
Hemophilia
Interventions
OTHER

Non interventional study

A query form to all concerned patients by each investigating centre will be send

Trial Locations (6)

29609

Brest University Hospital, Brest

35033

Rennes University Hospital, Rennes

37170

Tours University Hospital, Tours

49933

Angers University Hospital, Angers

69000

Lyon University Hospital, Lyon

72037

Le Mans Hospital, La Mans

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT03157154 - Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies | Biotech Hunter | Biotech Hunter